RedCarpetLife
1086
In the world today
Ye Chenghai & family

Ye Chenghai & family

Y. family
-0.14% | - $-5.39M
$3.91 B ₹ 35,580 Cr
Real Time Net Worth #1086 Ranking as of 21 Feb 2026 By Forbes

More on Ye Chenghai & family

Gender

Male

Age

82Y

Country

China

Born On

August, 1943

Deceased

No

Relationship Status

Married

Children

2

Education

Renmin University Of China - Bachelor Of Arts/Science

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Shenzhen Salubris Pharmaceuticals

Titles

Founder

Sources of Wealth

Pharmaceuticals

Industry

Healthcare, Pharmaceuticals

About Ye Chenghai & family


Y e Chenghai is a prominent Chinese businessman and the founder of Shenzhen Salubris Pharmaceuticals. A former politician, he served as the vice mayor of Shenzhen in the 1980s before leaving public office to enter the private sector. He founded Salubris in 1998, focusing on the development and manufacturing of cardiovascular, anti-cancer, and anti-infective drugs. The company has since grown into a leading player in China's pharmaceutical industry.

Ye took Salubris public on the Shenzhen Stock Exchange in 2009. He has passed the day-to-day management to his son, Kevin Ye (Ye Yuxiang), who serves as CEO, while his daughter Ye Yujun is also on the board. Ye Chenghai's career path from a high-ranking government official to a billionaire entrepreneur is a notable example of the economic reforms in China.

Advertisement

Quick Reads


Early Life and Background


Ye Chenghai is a Chinese businessman, a politician turned entrepreneur, who chairs Shenzhen Salubris Pharmaceuticals (SZSE: 002294). The company specializes in manufacturing cardiovascular, cancer and anti-infective drugs.

Ye served as the mayor of Shenzhen in the 1980s. His son, Kevin, is Salubris' CEO, and his daughter, Ye Yujun, is a board member.

  • Core Company: Shenzhen Salubris Pharmaceuticals (SZSE: 002294).
  • Prior Role: Served as mayor of Shenzhen in the 1980s.
  • Products: Manufactures cardiovascular, cancer and anti-infective drugs.

Career Journey of Ye Chenghai & family


Ye Chenghai’s career is defined by a significant transition from public administration to pharmaceutical entrepreneurship. His structural achievement lies in building Shenzhen Salubris into a specialized drug developer focusing on critical therapeutic areas.

The company's focus on high-value drugs like cardiovascular and cancer treatments has secured its market position. He maintains control of the company, with his children serving as key executives and board members, ensuring generational continuity.

Advertisement

Ye Chenghai & family's Timeline


1980s:

Served as mayor of Shenzhen.

Ongoing:

Founds and chairs Shenzhen Salubris Pharmaceuticals.

Ongoing:

Son Kevin serves as CEO and daughter Ye Yujun is a board member.

Major Business Ventures and Investments


Ye Chenghai's wealth is concentrated in his family's controlling stake and continued leadership of the publicly traded pharmaceutical giant, Shenzhen Salubris Pharmaceuticals.

  • Shenzhen Salubris Pharmaceuticals (Chairman): Supplier of specialized drugs.
  • Family Governance: Son Kevin is CEO; daughter Ye Yujun is a board member.
  • Sector Focus: Pharmaceuticals, specializing in cardiovascular, cancer, and anti-infective drugs.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is a politician turned entrepreneur who was the mayor of Shenzhen in the 1980s.
  • He chairs Shenzhen Salubris Pharmaceuticals, which makes cardiovascular, cancer and anti-infective drugs.
  • His son Kevin is the company's CEO.

Advertisement

More Profiles


Jaroslav Hascak & family

+0.21% | +$4.52M

Brendan Foody

0% | $0.00M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content